Acquisitions, Mix-Match Sputnik Light Booster On Dr Reddy’s Menu

Dr Reddy’s indicates it is actively pursuing acquisitions, likely involving relatively smaller assets, across several key markets on the back of a “healthy” balance sheet. It is also progressing plans to position Russian COVID-19 vaccine Sputnik Light as a booster, which it believes could potentially be “part of life” hereon.

Puzzle
Dr Reddy's active on deal street • Source: Alamy

Expect mergers and acquisition action, albeit for “smaller assets,” by Dr. Reddy's Laboratories Ltd. - the front-line Indian firm appears set to seal a deal or so sometime soon, if all goes per plan, going by senior management commentary at its fiscal third quarter earnings announcement.

Dr Reddy’s CEO Erez Israeli indicated that, in line with the company’s “aspiration and healthy balance sheet”, M&A remains an...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip